The correct way to take Moboxetinib (Anvili) and daily dosage recommendations

Mobocertinib is an oral targeted drug targeting EGFR 20 exon insertion mutations. It is mainly used to treat patients with post-treatment non-small cell lung cancer. As a new generation of selective EGFR inhibitors, correct dosage is crucial to ensure efficacy and reduce side effects. Patients should strictly follow the doctor's instructions to take the medication, and should not increase or decrease the dose at will or stop the medication on their own, so as not to affect the efficacy or lead to drug resistance.

In terms of taking method, mobosetinib is an oral drug. It is generally recommended to take it once a day at a fixed time to ensure stable blood concentration. Patients can choose to take it on an empty stomach or after eating, but it is best to take it in the same state every day (such as after meals every day) to avoid dietary differences affecting drug absorption. When swallowing, the tablet should be swallowed whole and should not be broken or chewed to ensure normal release and absorption of the drug in the body.

Concerning daily dosage, a common recommended dose is 160mg/day. However, it should be noted that the specific dosage may be adjusted by the doctor based on the patient's constitution, liver and kidney function, side effects and other factors. When serious adverse reactions occur, the doctor may recommend temporarily stopping the medication or reducing the dose, so patients should not change the dose on their own.

In addition, patients should pay attention to interactions with other drugs while taking the drug. Some drugs (such as strong CYP3A inhibitors or inducers) may affect the metabolism of moboxetinib, thereby reducing efficacy or increasing the risk of side effects. Therefore, during the use of mobosetinib, you should proactively inform your doctor of all drugs, health products, or Chinese herbal medicines you are taking to ensure drug safety.

Reference link:https://www.drugs.com